Zhao et al. demonstrated that combined treatment with IRE and anti-PD-1 Ab resulted in increased infiltration of intratumoral CD8+ T cells and improved OS in a pancreatic cancer mouse model [148]. The gene discussed is CD8A; the disease is pancreatic neoplasm.